Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Jun 2026 for Axsome Therapeutics, Inc., €139k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Coleman Mark: trading record in brief
All filings by Coleman Mark on record concern Axsome Therapeutics, Inc. The record holds 2 filings, for trades running from 2 June 2026 to 10 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 10 June 2026: a transaction of €139k, in Axsome Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Coleman Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
643 shares@ US$249.0031CommonSEC144:0001921094-26-000631
1 of 1 declaration
